What is post-exertional malaise (PEM) and how is it different from normal tiredness?

PEM is a worsening of symptoms after activity that would have been easy before becoming unwell — a short walk, a phone call, a stressful conversation, or a busy work morning. The crash is typically delayed by 12 to 48 hours, then lasts at least a day and often days or weeks. It is not relieved by a good night of sleep. People often describe an energy envelope — a daily ceiling they can stay inside without paying a heavy penalty later. Normal tiredness improves with rest within hours. PEM does not, and pushing through it generally makes things worse rather than building tolerance.

How is ME/CFS diagnosed in Australia?

There is no single test for ME/CFS. Diagnosis is clinical, using the NICE NG206 2021 framework while the NHMRC Australian guideline is being developed. A GP looks for at least three months of post-exertional malaise plus persistent fatigue, unrefreshing sleep, and cognitive impairment such as poor concentration or word-finding difficulty. A careful history, examination, and structured blood-test panel rule out other conditions that can mimic ME/CFS — thyroid disease, coeliac disease, anaemia, vitamin deficiencies, sleep apnoea, autoimmune disease, and chronic infections. Severity is graded from mild through moderate, severe, and very severe, which guides what support a person needs.

Is long COVID the same as ME/CFS?

There is significant overlap but they are not identical. A large subgroup of people with long COVID meet ME/CFS criteria once the picture has been stable for at least three months, particularly when post-exertional malaise is prominent. Long COVID can include features that sit outside the ME/CFS pattern — for example persistent loss of smell or taste, ongoing inflammatory markers, or specific organ-system symptoms after the acute infection. The pacing-based management framework is broadly the same, but additional COVID-specific assessment and clinics may also be helpful where available.

Why is graded exercise therapy no longer recommended?

Older approaches assumed that ME/CFS was driven by deconditioning, and that gradually increasing exercise would reverse it. After re-examining the evidence, NICE removed graded exercise therapy from its 2021 ME/CFS guideline because the trial evidence was downgraded to low or very low quality and a clear signal of harm was identified in PEM-driven illness. Patient-survey data consistently shows worsening with structured exercise progression. If a person previously tried graded exercise therapy and felt worse, this is a real signal, not a personal failure. Gentle movement within the energy envelope is still encouraged where tolerated.

What is pacing and how do I actually do it?

Pacing means staying inside your energy envelope — the level of activity you can do without triggering post-exertional malaise. The practical pattern is: rest before symptoms appear, not after; break tasks into short blocks with planned breaks; prioritise the activities that matter most and let lower-priority ones go; and use a simple symptom diary to learn your patterns. Cognitive activity counts, not just physical activity, so reading, screens, conversations, and decision-making all draw on the same envelope. An occupational therapist or physiotherapist with experience in ME/CFS can help personalise this. Over time, many people find their baseline lifts gently if they protect it consistently.

When should I see my GP about ongoing fatigue?

See a GP if fatigue has been present for more than a few weeks, is not explained by an obvious short-term cause, and is affecting your work, study, or daily life. Earlier review is reasonable if the fatigue started after an infection such as COVID-19, glandular fever, or another viral illness, particularly if you notice a delayed crash after activity. Urgent review is appropriate for new red flags — unexplained weight loss, fevers, night sweats, severe headaches, vision changes, focal weakness, or new mental-health concerns including thoughts of self-harm. Severe ME/CFS that leaves a person housebound or bedbound also warrants escalation, including consideration of home visits and disability support.

Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS)

ME/CFS and long COVID fatigue: diagnosis, pacing, and when to see a GP

By Dr HB Lo, FACRRM Reviewed 2 June 2026 8 min read

ME/CFS is a chronic, multisystem biological illness, not deconditioning or depression. Its defining feature is post-exertional malaise (PEM) — a delayed, prolonged crash 12 to 48 hours after physical, cognitive, or emotional effort.

Diagnosis follows the NICE NG206 2021 framework while the NHMRC Australian guideline is being developed: at least three months of PEM, persistent fatigue, unrefreshing sleep, and cognitive impairment, after careful exclusion of other causes.

Management is built on pacing within an energy envelope. Graded exercise therapy is no longer recommended. Sleep, pain, and orthostatic symptoms are managed alongside, and severe impairment can qualify for NDIS support.

What ME/CFS actually is

Myalgic encephalomyelitis / chronic fatigue syndrome — ME/CFS — is a chronic, multisystem biological illness. It is not deconditioning, not depression, not a personality trait, and not a problem of motivation. The defining feature is post-exertional malaise (PEM): a delayed and prolonged worsening of symptoms after physical, cognitive, or emotional effort that would once have been unremarkable.

Estimates from Emerge Australia suggest around 250,000 Australians live with ME/CFS, roughly 0.2 to 2 per cent of adults. It affects women about three times more often than men, with most people first becoming unwell between the ages of 20 and 50. Children and adolescents are also affected. Many people develop ME/CFS after an infection — historically Epstein-Barr virus, Q fever, and other viral or post-viral triggers — and since 2020 a substantial number have developed it after COVID-19, often as part of the long COVID picture.

Research into mechanism is active but still incomplete. Findings to date point toward immune dysregulation, problems with energy metabolism, microcirculatory and autonomic dysfunction, and neuroinflammation. The lack of a single biomarker does not mean the illness is psychological. It means the biology is complex and the science is still catching up.

This article explains how ME/CFS is recognised and diagnosed in Australian general practice, what management actually involves, and when to see a GP — including how the picture overlaps with long COVID.

How ME/CFS is diagnosed

There is no blood test or scan that confirms ME/CFS. Diagnosis is clinical, using a defined set of criteria after other conditions have been carefully excluded.

The current operational standard is the NICE NG206 2021 guideline. The NHMRC is developing the first Australian guideline in more than two decades, with input from the RACGP and consumer groups. Until that is published, NICE NG206 is the framework most Australian GPs and specialists are working from, alongside Emerge Australia’s position statement.

The core criteria

NICE NG206 looks for at least three months of all of the following:

Post-exertional malaise — symptom worsening after activity, typically delayed by 12 to 48 hours and lasting a day or more
Persistent fatigue that is not explained by ongoing effort and not relieved by rest
Unrefreshing sleep — waking exhausted regardless of how long the night was
Cognitive impairment — difficulty with concentration, memory, processing speed, or word-finding, often described as brain fog

Many people also experience orthostatic intolerance (light-headedness, palpitations, or feeling worse on standing), pain, sensory hypersensitivity, and gut symptoms. Severity is graded from mild (independent for most activities, struggling at work or school) through moderate (housework restricted, often unable to work) and severe (housebound) to very severe (bedbound and dependent on a carer).

Ruling out other causes

Several conditions cause persistent fatigue and need to be considered before a diagnosis of ME/CFS is made. A typical first-line workup, drawn from NICE NG206 and Australian general practice, includes:

Full blood count, ESR and CRP
Iron studies and ferritin
Vitamin B12, folate, vitamin D
Thyroid function tests
Liver and kidney function, calcium, magnesium
Coeliac antibodies
HbA1c and fasting glucose
HIV and hepatitis B and C serology where appropriate
Autoimmune screen (ANA and extractable nuclear antigens) if features suggest it
8 am cortisol if adrenal insufficiency is being considered

A sleep study is added if obstructive sleep apnoea features are present — snoring, witnessed pauses in breathing, or significant daytime sleepiness. A tilt-table test can confirm postural orthostatic tachycardia syndrome (POTS) when symptoms suggest it.

Conditions to consider and exclude include thyroid disease, coeliac disease, anaemia, sleep apnoea, depression and anxiety, autoimmune disease such as lupus or Sjogren’s, multiple sclerosis, chronic infections, Addison’s disease, and malignancy. Major depression and ME/CFS can both involve low energy, but the patterns differ — depression centres on persistent low mood, anhedonia, and self-critical thinking, while ME/CFS centres on PEM and a body that cannot recover from effort despite normal motivation and interest. The CDC ME/CFS clinical resource lays out this differentiation in detail.

Marketed test panels that promise to diagnose ME/CFS through unconventional immune, viral, or heavy-metal markers are not recommended. Most lack validation, generate misleading false positives, and add cost without changing management.

ME/CFS and long COVID

Many people developing ME/CFS over the past five years did so after a COVID-19 infection. A meaningful proportion of long COVID — perhaps a quarter to a half, depending on the cohort — meet ME/CFS criteria once symptoms have been stable for at least three months and PEM is present. The overlap matters because the management framework is similar: pace within an energy envelope, manage orthostatic symptoms, sleep, and pain, and support function rather than chase a cure.

Some long COVID features sit outside the classic ME/CFS picture, including persistent loss of smell or taste, ongoing inflammation, and specific cardiopulmonary or neurological complications. Dedicated post-COVID clinics exist in some Australian capital cities and can complement GP care. Long COVID Australia is a useful starting point for consumer-facing information.

How ME/CFS is managed

There is currently no cure for ME/CFS. The aim of treatment is to stabilise function, prevent crashes, manage symptoms, and protect quality of life. The cornerstones — set out in NICE NG206, Emerge Australia’s position statement, and eTG — are pacing, symptom management, and comprehensive support.

Pacing, not pushing

Pacing means staying within an energy envelope so PEM is not triggered. The practical principles are simple, but learning them in your own life is harder than it sounds:

Rest before symptoms appear, not after
Break tasks into shorter blocks with planned breaks
Treat cognitive effort (screens, conversations, decisions) as part of the same energy budget as physical effort
Prioritise the activities that matter most and let lower-priority ones go
Keep a brief symptom diary to learn your personal patterns

Graded exercise therapy — a structured, time-based progression of physical activity — is no longer recommended for ME/CFS. After re-examining the evidence, NICE NG206 downgraded trial data to low quality and identified a consistent harm signal. If you tried graded exercise therapy in the past and felt worse, that was a real signal, not a personal failing.

Gentle movement within your envelope — short walks, stretching, yoga, tai chi — can still have a place where it does not provoke PEM. An occupational therapist or physiotherapist familiar with ME/CFS can help calibrate this.

Cognitive behavioural therapy (CBT) has a role in adjustment, coping, and managing comorbid mood or anxiety. It is not a cure for ME/CFS, and framing it as such has caused harm. Used appropriately, it can sit alongside the rest of the plan.

Sleep, pain, and orthostatic symptoms

Sleep is often disturbed and unrefreshing. A consistent sleep-wake schedule, daylight in the morning, limiting late stimulants, and treating any underlying sleep apnoea all help. Low-dose tricyclics such as amitriptyline at bedtime, and prolonged-release melatonin, are sometimes used under GP review.

Pain — muscle, joint, or headache — is common. Paracetamol is the first-line option. NSAIDs can be used with caution. Tricyclics, duloxetine, and other agents have a role in selected cases under GP or specialist guidance. Long-term opioids are generally avoided.

Orthostatic intolerance and POTS often respond well to simple measures: 2 to 3 litres of fluid a day, increased salt intake (in the absence of high blood pressure), graduated compression stockings, raising the head of the bed, and avoiding prolonged standing. Medications such as midodrine, fludrocortisone, or a low-dose beta-blocker may be added where symptoms are severe and a GP or cardiologist is involved.

Brain fog responds to the same pacing principle applied to cognitive load — short focused blocks, frequent breaks, written reminders, simplified routines, and a quieter sensory environment.

Support, work, and disability

ME/CFS frequently affects work, study, and the ability to manage household tasks. Australian support structures include:

Mental Health Care Plans through general practice, which provide subsidised psychology sessions for adjustment and any comorbid mood or anxiety
Chronic disease management planning for ongoing GP-led care and allied health input
The NDIS, which recognises severe and very severe ME/CFS as qualifying for support — documentation of severity, PEM-related functional limits, and comorbidities matters here
Centrelink Disability Support Pension and sickness benefits, with GP documentation supporting eligibility
Workplace and education accommodations such as reduced hours, flexible scheduling, and remote work
Carer support and payments for those caring for severely affected family members

Emerge Australia is the national peak body and a useful resource for both patients and families.

When to see a GP

It is reasonable to see a GP if:

Fatigue has lasted more than a few weeks and is not explained by an obvious short-term cause
Fatigue is affecting your work, study, relationships, or daily life
You notice a delayed crash after activity that lasts a day or more
Symptoms started after an infection — including COVID-19 — and have not settled
A previous diagnosis of ME/CFS is not being managed actively and you would like a structured review

Earlier review is appropriate for new red flags: unexplained weight loss, ongoing fevers or night sweats, severe headaches, vision changes, focal weakness or numbness, swollen lymph nodes that do not settle, or worsening mental health including thoughts of self-harm.

Urgent contact is appropriate for severe orthostatic syncope, an acute deterioration with concerning features, or any thoughts of self-harm. In a crisis, Lifeline on 13 11 14 and Beyond Blue on 1300 22 4636 are available around the clock.

For severe or very severe ME/CFS where leaving the house is not possible, telehealth and home visits can be discussed with your GP.

What this article is and is not

This is general health information drawn from current clinical guidelines — particularly NICE NG206 2021, Emerge Australia’s position, the RACGP submission to the NHMRC scoping process, eTG complete, and the CDC ME/CFS clinical resources. It is not personal medical advice and does not create a doctor–patient relationship. Decisions about your own diagnosis, investigations, and treatment are made with your own GP and specialist clinicians.

For Australian consumer-friendly information: HealthDirect · Better Health Channel · Emerge Australia · Long COVID Australia.

For acute mental-health crisis: Lifeline 13 11 14 · Beyond Blue 1300 22 4636.

Sources cited

Frequently asked questions

What is post-exertional malaise (PEM) and how is it different from normal tiredness?

PEM is a worsening of symptoms after activity that would have been easy before becoming unwell — a short walk, a phone call, a stressful conversation, or a busy work morning. The crash is typically delayed by 12 to 48 hours, then lasts at least a day and often days or weeks. It is not relieved by a good night of sleep. People often describe an energy envelope — a daily ceiling they can stay inside without paying a heavy penalty later. Normal tiredness improves with rest within hours. PEM does not, and pushing through it generally makes things worse rather than building tolerance.
How is ME/CFS diagnosed in Australia?

There is no single test for ME/CFS. Diagnosis is clinical, using the NICE NG206 2021 framework while the NHMRC Australian guideline is being developed. A GP looks for at least three months of post-exertional malaise plus persistent fatigue, unrefreshing sleep, and cognitive impairment such as poor concentration or word-finding difficulty. A careful history, examination, and structured blood-test panel rule out other conditions that can mimic ME/CFS — thyroid disease, coeliac disease, anaemia, vitamin deficiencies, sleep apnoea, autoimmune disease, and chronic infections. Severity is graded from mild through moderate, severe, and very severe, which guides what support a person needs.
Is long COVID the same as ME/CFS?

There is significant overlap but they are not identical. A large subgroup of people with long COVID meet ME/CFS criteria once the picture has been stable for at least three months, particularly when post-exertional malaise is prominent. Long COVID can include features that sit outside the ME/CFS pattern — for example persistent loss of smell or taste, ongoing inflammatory markers, or specific organ-system symptoms after the acute infection. The pacing-based management framework is broadly the same, but additional COVID-specific assessment and clinics may also be helpful where available.
Why is graded exercise therapy no longer recommended?

Older approaches assumed that ME/CFS was driven by deconditioning, and that gradually increasing exercise would reverse it. After re-examining the evidence, NICE removed graded exercise therapy from its 2021 ME/CFS guideline because the trial evidence was downgraded to low or very low quality and a clear signal of harm was identified in PEM-driven illness. Patient-survey data consistently shows worsening with structured exercise progression. If a person previously tried graded exercise therapy and felt worse, this is a real signal, not a personal failure. Gentle movement within the energy envelope is still encouraged where tolerated.
What is pacing and how do I actually do it?

Pacing means staying inside your energy envelope — the level of activity you can do without triggering post-exertional malaise. The practical pattern is: rest before symptoms appear, not after; break tasks into short blocks with planned breaks; prioritise the activities that matter most and let lower-priority ones go; and use a simple symptom diary to learn your patterns. Cognitive activity counts, not just physical activity, so reading, screens, conversations, and decision-making all draw on the same envelope. An occupational therapist or physiotherapist with experience in ME/CFS can help personalise this. Over time, many people find their baseline lifts gently if they protect it consistently.
When should I see my GP about ongoing fatigue?

See a GP if fatigue has been present for more than a few weeks, is not explained by an obvious short-term cause, and is affecting your work, study, or daily life. Earlier review is reasonable if the fatigue started after an infection such as COVID-19, glandular fever, or another viral illness, particularly if you notice a delayed crash after activity. Urgent review is appropriate for new red flags — unexplained weight loss, fevers, night sweats, severe headaches, vision changes, focal weakness, or new mental-health concerns including thoughts of self-harm. Severe ME/CFS that leaves a person housebound or bedbound also warrants escalation, including consideration of home visits and disability support.

Source quality

Sources grouped by evidence tier. AU primary tier first; international where AU is silent or lagging; named-author reconstruction where guidelines have not yet caught up. How tiers work.

T1 AU primary 8 sources
T2 International primary 2 sources
- NICE NG206 — ME/CFS diagnosis and management 2021
- CDC — ME/CFS clinical resources